Skip to main content

Prospective observational cohort of patients with moderate-to-severe SLE to characterize cross-sectional and longitudinal disease activity, treatment patterns and effectiveness, outcomes and comorbidities, healthcare resource utilization

Research Grant
Duke Scholars

Administered By

Medicine, Rheumatology and Immunology

Awarded By

AstraZeneca Pharmaceuticals, LP

Start Date

August 28, 2018

End Date

July 31, 2023
 

Administered By

Medicine, Rheumatology and Immunology

Awarded By

AstraZeneca Pharmaceuticals, LP

Start Date

August 28, 2018

End Date

July 31, 2023